CureVac releases mixed interim Phase 2 data for seasonal flu vaccine
CureVac’s seasonal flu vaccine boosted antibody titers in influenza A strains but it missed the mark in influenza B in a Phase 2 trial. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
